Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey

Yozgat A., Kasapoglu B., Demirci S., Sokmen F. C.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, cilt.113, sa.7, ss.490-493, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 113 Sayı: 7
  • Basım Tarihi: 2021
  • Doi Numarası: 10.17235/reed.2020.7261/2020
  • Dergi Adı: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals, DIALNET
  • Sayfa Sayıları: ss.490-493
  • Anahtar Kelimeler: H. pylori, Quadruple therapy, First-line treatment, ANTIBIOTIC-RESISTANCE, ANTIMICROBIAL RESISTANCE, CLARITHROMYCIN, ERADICATION, METRONIDAZOLE, AMOXICILLIN, TRIAL
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Aim: Helicobacter pylori (H. pylori) eradication is still an important issue in countries with high antibiotic resistance. This study aimed to compare the efficacy and safety of two bismuth-containing treatment modalities in H. pyloritreatment in Turkey.